Archive

Military Healthcare: A Lifeline of Stability for Those Who Serve

Military Healthcare: A Lifeline of Stability for Those Who Serve

Over the past decade, the percentage of people insured by military healthcare in the United States has remained relatively steady, demonstrating the enduring commitment of the U.S. government to providing comprehensive coverage for military personnel, veterans, and their families.

Weekly IssueWeekly Issue
New therapies, new rivals—will the US stay on top?

New therapies, new rivals—will the US stay on top?

This week we dive into the Pharma R&D market, with total spending projected to skyrocket to $366B by 2030.

Deep DiveDeep Dive
Trends and Finance of R&D in Pharmaceutical Industry

Trends and Finance of R&D in Pharmaceutical Industry

Research and Development spending is growing rapidly at a global level. According to Evaluate Pharma, the total global spending in Pharma R&D was $161 billion in 2016 and reached the total value of $306 billion in 2024.

Weekly IssueWeekly Issue
Med Devices: The Unstoppable Revolution

Med Devices: The Unstoppable Revolution

This week we dive into the Medical devices market, with market revenues projected to skyrocket to $670B by 2029.

Deep DiveDeep Dive
The Pulse of Innovation: Unpacking the Future of Medical Devices

The Pulse of Innovation: Unpacking the Future of Medical Devices

The medical devices industry is at the forefront of a healthcare revolution, driven by technological advancements, shifting patient needs, and increasing global healthcare expenditures.

Weekly IssueWeekly Issue
Healthcare Plunge: did M&A peak in 2021?

Healthcare Plunge: did M&A peak in 2021?

This week we dive into the Telemedicine market, with $35.8B in online consultations revenue by 2028.

Deep DiveDeep Dive
From Pandemic Necessity to Market Opportunity: The Business of Telemedicine

From Pandemic Necessity to Market Opportunity: The Business of Telemedicine

The healthcare industry is undergoing a digital transformation, and at the forefront is telemedicine, reshaping how patients access care and how providers deliver it.

Weekly IssueWeekly Issue
Cardio’s New Boom: Is $26B just the start?

Cardio’s New Boom: Is $26B just the start?

This week we dive into the explosive $1.51 trillion-dollar biotech market.

Deep DiveDeep Dive
Biotech Boom: A Market on the Rise

Biotech Boom: A Market on the Rise

The biotechnology industry is at an inflection point, poised for unprecedented growth, innovation, and investment opportunities.

Weekly IssueWeekly Issue
Healthcare CFOs: is spending big the only fix?

Healthcare CFOs: is spending big the only fix?

Big Pharma just hit the gym, and the obesity drug market is bulking up fast. With a projected CAGR of 27.5%, this segment is set to balloon from $20.2B in 2024 to $86.7B by 2030—making it one of the fastest-growing therapy areas alongside oncology and diabetes.

Deep DiveDeep Dive
Obesity Drugs Market: a stable and high growing segment

Obesity Drugs Market: a stable and high growing segment

Anti-obesity medications are designed to support weight loss in individuals who are overweight or obese. These drugs operate through various mechanisms, such as reducing appetite, enhancing metabolism, or blocking the absorption of dietary fat.

Weekly IssueWeekly Issue
AI’s new hustle: curing us all?

AI’s new hustle: curing us all?

This week, we dive into the $1.13T opportunity of digital health space. Growing at a CAGR of 19.28% till 2032, digital health promises high returns for healthcare investors.

FirstBack
1234
Next Last